Benitec Biopharma Inc. (BNTC) Scorecard
- 2026-Q2: Total return Win; Revenue growth Lose; EPS growth Lose.
- 2026-Q1: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2025-Q4: Total return Lose; Revenue growth Lose; EPS growth Win.
- 2025-Q3: Total return Win; Revenue growth Lose; EPS growth Lose.
24/120
All 120 Win/Lose results shown below
Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.
Trailing 1 year (4 quarters): 3 wins, 9 lossesLast fetched: 4 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q21/3 |
WinBNTC / S&P 25.63% / 15.20% |
LoseBNTC / S&P BNTC unavailable / 15.00% |
LoseBNTC / S&P BNTC unavailable / 50.40% |
| 2026-Q10/3 |
LoseBNTC / S&P -20.94% / -4.33% |
LoseBNTC / S&P BNTC unavailable / 11.30% |
LoseBNTC / S&P 0.00% / 27.70% |
| 2025-Q41/3 |
LoseBNTC / S&P -3.99% / 2.65% |
LoseBNTC / S&P BNTC unavailable / 9.00% |
WinBNTC / S&P 37.18% / 13.40% |
| 2025-Q31/3 |
WinBNTC / S&P 19.91% / 8.12% |
LoseBNTC / S&P BNTC unavailable / 4.61% |
LoseBNTC / S&P -66.14% / 13.45% |
| 2025-Q20/3 |
LoseBNTC / S&P -10.07% / 10.94% |
LoseBNTC / S&P BNTC unavailable / 4.83% |
LoseBNTC / S&P -82.92% / 10.63% |
| 2025-Q11/3 |
WinBNTC / S&P 3.01% / -4.27% |
LoseBNTC / S&P -100.00% / 4.98% |
LoseBNTC / S&P -89.15% / 10.57% |
| 2024-Q41/3 |
WinBNTC / S&P 37.43% / 2.41% |
LoseBNTC / S&P -100.00% / 5.25% |
LoseBNTC / S&P -92.92% / 6.15% |
| 2024-Q31/3 |
WinBNTC / S&P 31.47% / 5.89% |
LoseBNTC / S&P -100.00% / 5.89% |
LoseBNTC / S&P -73.01% / 6.11% |
| 2024-Q21/3 |
WinBNTC / S&P 33.14% / 4.28% |
LoseBNTC / S&P -100.00% / 5.38% |
LoseBNTC / S&P -63.76% / 5.12% |
| 2024-Q11/3 |
WinBNTC / S&P 62.54% / 10.56% |
LoseBNTC / S&P -89.71% / 5.71% |
LoseBNTC / S&P -82.95% / 5.59% |
| 2023-Q40/3 |
LoseBNTC / S&P 6.88% / 11.69% |
LoseBNTC / S&P -1.61% / 6.81% |
LoseBNTC / S&P -77.06% / 7.78% |
| 2023-Q30/3 |
LoseBNTC / S&P -25.62% / -3.27% |
LoseBNTC / S&P 2.74% / 7.52% |
LoseBNTC / S&P -74.12% / -5.03% |
| 2023-Q21/3 |
WinBNTC / S&P 13.81% / 8.74% |
LoseBNTC / S&P 2.74% / 9.50% |
LoseBNTC / S&P -56.07% / -8.57% |
| 2023-Q11/3 |
WinBNTC / S&P 23.53% / 7.50% |
LoseBNTC / S&P -9.33% / 10.77% |
LoseBNTC / S&P BNTC unavailable / -15.69% |
| 2022-Q41/3 |
LoseBNTC / S&P -54.30% / 7.56% |
WinBNTC / S&P 121.43% / 11.88% |
LoseBNTC / S&P BNTC unavailable / -17.99% |
| 2022-Q31/3 |
LoseBNTC / S&P -67.93% / -4.88% |
WinBNTC / S&P 1725.00% / 13.47% |
LoseBNTC / S&P BNTC unavailable / -1.41% |
| 2022-Q21/3 |
LoseBNTC / S&P -50.32% / -16.10% |
WinBNTC / S&P 23.73% / 13.71% |
LoseBNTC / S&P BNTC unavailable / 11.04% |
| 2022-Q11/3 |
LoseBNTC / S&P -10.88% / -4.60% |
WinBNTC / S&P 341.18% / 15.97% |
LoseBNTC / S&P BNTC unavailable / 42.23% |
| 2021-Q40/3 |
LoseBNTC / S&P -26.61% / 11.03% |
LoseBNTC / S&P -36.36% / 15.00% |
LoseBNTC / S&P BNTC unavailable / 96.40% |
| 2021-Q30/3 |
LoseBNTC / S&P -16.00% / 0.58% |
LoseBNTC / S&P -96.67% / 10.77% |
LoseBNTC / S&P BNTC unavailable / 69.42% |
| 2021-Q20/3 |
LoseBNTC / S&P -17.79% / 8.55% |
LoseBNTC / S&P -39.80% / 6.58% |
LoseBNTC / S&P BNTC unavailable / 51.81% |
| 2021-Q11/3 |
WinBNTC / S&P 72.33% / 6.17% |
LoseBNTC / S&P BNTC unavailable / -1.06% |
LoseBNTC / S&P BNTC unavailable / 7.39% |
| 2020-Q40/3 |
LoseBNTC / S&P -52.23% / 12.15% |
LoseBNTC / S&P BNTC unavailable / -3.72% |
LoseBNTC / S&P BNTC unavailable / -33.42% |
| 2020-Q30/3 |
LoseBNTC / S&P -20.61% / 8.93% |
LoseBNTC / S&P BNTC unavailable / -2.04% |
LoseBNTC / S&P BNTC unavailable / -27.10% |
| 2020-Q21/3 |
WinBNTC / S&P 34.18% / 20.54% |
LoseBNTC / S&P BNTC unavailable / -0.46% |
LoseBNTC / S&P BNTC unavailable / -27.11% |
| 2020-Q10/3 |
LoseBNTC / S&P -22.94% / -19.60% |
LoseBNTC / S&P BNTC unavailable / 3.47% |
LoseBNTC / S&P BNTC unavailable / -14.75% |
| 2019-Q40/3 |
LoseBNTC / S&P -28.27% / 9.07% |
LoseBNTC / S&P BNTC unavailable / 5.36% |
LoseBNTC / S&P BNTC unavailable / 2.99% |
| 2019-Q30/3 |
LoseBNTC / S&P -5.07% / 1.70% |
LoseBNTC / S&P BNTC unavailable / 5.02% |
LoseBNTC / S&P BNTC unavailable / 0.21% |
| 2019-Q20/3 |
LoseBNTC / S&P -61.79% / 4.30% |
LoseBNTC / S&P BNTC unavailable / 6.64% |
LoseBNTC / S&P BNTC unavailable / 8.65% |
| 2019-Q11/3 |
WinBNTC / S&P 30.67% / 13.65% |
LoseBNTC / S&P BNTC unavailable / 8.12% |
LoseBNTC / S&P BNTC unavailable / 14.29% |
| 2018-Q40/3 |
LoseBNTC / S&P -36.71% / -13.52% |
LoseBNTC / S&P BNTC unavailable / 9.05% |
LoseBNTC / S&P BNTC unavailable / 18.23% |
| 2018-Q31/3 |
WinBNTC / S&P 19.10% / 7.71% |
LoseBNTC / S&P BNTC unavailable / 10.21% |
LoseBNTC / S&P BNTC unavailable / 19.06% |
| 2018-Q20/3 |
LoseBNTC / S&P -37.43% / 3.43% |
LoseBNTC / S&P BNTC unavailable / 9.03% |
LoseBNTC / S&P BNTC unavailable / 14.46% |
| 2018-Q11/3 |
WinBNTC / S&P 7.57% / -0.76% |
LoseBNTC / S&P BNTC unavailable / 7.68% |
LoseBNTC / S&P BNTC unavailable / 12.46% |
| 2017-Q41/3 |
WinBNTC / S&P 36.41% / 6.64% |
LoseBNTC / S&P BNTC unavailable / 7.03% |
LoseBNTC / S&P BNTC unavailable / 13.82% |
| 2017-Q31/3 |
WinBNTC / S&P 17.30% / 4.48% |
LoseBNTC / S&P BNTC unavailable / 5.68% |
LoseBNTC / S&P BNTC unavailable / 17.57% |
| 2017-Q20/3 |
LoseBNTC / S&P -32.97% / 3.09% |
LoseBNTC / S&P BNTC unavailable / 4.83% |
LoseBNTC / S&P BNTC unavailable / 17.74% |
| 2017-Q11/3 |
WinBNTC / S&P 80.39% / 6.07% |
LoseBNTC / S&P BNTC unavailable / 3.67% |
LoseBNTC / S&P BNTC unavailable / 13.32% |
| 2016-Q41/3 |
WinBNTC / S&P 9.29% / 3.82% |
LoseBNTC / S&P BNTC unavailable / 2.09% |
LoseBNTC / S&P BNTC unavailable / 7.05% |
| 2016-Q31/3 |
WinBNTC / S&P 10.41% / 3.85% |
LoseBNTC / S&P BNTC unavailable / 0.20% |
LoseBNTC / S&P BNTC unavailable / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-27
| Metric | BNTC total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -4.31% | 20.78% |
| Annualized return | -4.31% | 20.78% |
5Y · 2021-09-01 to 2026-08-27
| Metric | BNTC total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -81.27% | 83.14% |
| Annualized return | -28.47% | 12.86% |
10Y · 2016-09-01 to 2026-08-27
| Metric | BNTC total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -97.24% | 319.30% |
| Annualized return | -30.15% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-04.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| Larimar Therapeutics, Inc. (LRMR) | United States | $0.344B | -1.83 |
| Emergent BioSolutions Inc. (EBS) | United States | $0.347B | -2.43 |
| ENANTA PHARMACEUTICALS INC (ENTA) | United States | $0.349B | -6.72 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| Vogenx, Inc. (VOGX) | United States | $0.355B | |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |